2092
A. D. Moorhouse, J. E. Moses
LETTER
Table 1 Results for One-Pot Azidation and Cu(I)-Catalysed Huisgen Reaction (continued)
Entry
21
Aniline
Alkyne
Product
Yield (%)
98e
N
N
N
NH2
23
I
I
a Reaction conditions (azidation): TMSN3 (1 equiv), t-BuONO (1 equiv), MeCN, r.t., 2 min.
b Reaction conditions (azidation): TMSN3 (1.2 equiv), t-BuONO (1.5 equiv), MeCN, r.t., 2 h.
c Reaction conditions (azidation): TMSN3 (1 equiv), t-BuONO (1 equiv), MeCN, r.t., 30 min.
d Reaction conditions [Cu(I) step]: CuSO4·5H2O (0.1 equiv), sodium ascorbate (0.5 equiv), acetylene (1.5 equiv), MW, 80 °C (125 W max), 10
min.
e Reaction was complete, MW, 80 °C (125 W max), 2 min.
(11) Fukuzawa, S.-I.; Shimizu, E.; Kikucki, S. Synlett 2007,
Acknowledgment
2436.
We thank EPSRC and The University of Nottingham for funding
JEM and ADM. We thank Professor K. B. Sharpless for fruitful dis-
cussions and Professor C. J. Moody for helpful advice. Thanks are
also due to Dr. R. Stockman for use of his microwave reactor.
(12) Beckmann, H. S. G.; Wittmann, V. Org. Lett. 2007, 9, 1.
(13) Barral, K.; Moorhouse, A. D.; Moses, J. E. Org. Lett. 2007,
9, 1809.
(14) Typical Procedure – Synthesis of 4-{4-(4-Methoxyphen-
yl)-[1,2,3]triazol-1-yl}benzonitrile (1)
To a stirred solution of 4-aminobenzonitrile (200 mg, 1.69
mmol) in MeCN (2 mL) was added t-BuONO (0.22 mL, 1.69
References and Notes
mmol) at 0 °C in a 2–5 mL microwave reaction vial. To this
solution was added TMSN3 (0.20 mL, 1.69 mmol) dropwise
at 0 °C. The solution was stirred for 2 min at r.t., before
completion of transformation to azide (monitored by TLC).
At this point, 1-ethynyl 4-methoxybenzene (0.33 mL, 2.54
mmol) was added to the reaction mixture, followed by the
addition of CuSO4·5H2O (42 mg, 0.169 mmol) and sodium
ascorbate (167 mg, 0.845 mmol) in H2O (1 mL). The vial
was capped, then placed in a microwave reactor, and heated
to 80 °C (125 W max) (Biotage® Initiator 2.0, 400 W). The
reaction mixture was stirred at this temperature for 10 min
before completion of reaction was observed by TLC
(1) (a) Bräse, S.; Gil, C.; Knepper, K.; Zimmermann, V. Angew.
Chem. Int. Ed. 2005, 44, 5188. (b) Scriven, E. F. V.;
Turnbull, K. Chem. Rev. 1988, 88, 297.
(2) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem. Int.
Ed. 2001, 40, 2004.
(3) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless,
K. B. Angew. Chem. Int. Ed. 2002, 41, 2596.
(4) (a) Moorhouse, A. D.; Moses, J. E. ChemMedChem 2008, 3,
715. (b) Tron, G. C.; Pirali, T.; Billington, R. A.; Canonico,
P. L.; Sorba, G.; Genazzani, A. A. Med. Res. Rev. 2008, 28,
278. (c) Kolb, H. C.; Sharpless, K. B. Drug Discov. Today
2003, 8, 1128.
analysis. The product was then precipitated by the addition
of H2O (25 mL). The product was isolated by filtration then
washed with H2O (2 × 10 mL), then PE (40–60, 2 × 10 mL).
This gave the product as an orange powder (423 mg, 91%).
IR (CHCl3): 3010.24 (CH), 2234.19 (C≡N) cm–1. 1H NMR
(400 MHz, DMSO): d = 3.81 (s, 3 H, CH3), 7.07 (d, J = 8.9
Hz, 2 H, 2 × CH), 7.86 (d, J = 8.9 Hz, 2 H, 2 × CH), 8.11 (d,
J = 9.0 Hz, 2 H, 2 × CH), 8.17 (d, J = 9.0 Hz, 2 H, 2 × CH),
9.32 (s, 1 H, CH). 13C NMR (100 MHz, DMSO): d = 55.1,
110.8, 114.4, 118.0, 118.6, 120.1, 122.2, 128.7, 134.2,
139.4, 147.6, 159.4. HRMS: m/z calcd for C16H13N4O:
277.1084; found: 277.1076. Anal. Calcd for C16H12N4O: C,
69.55; H, 4.38; N, 20.28; Found: C, 69.32; H, 4.32; N, 20.11.
(5) Moses, J. E.; Moorhouse, A. D. Chem. Soc. Rev. 2007, 36,
1249.
(6) (a) Binder, W. H.; Kluger, C. Curr. Org. Chem. 2006, 10,
1791. (b) Hawker, C. J.; Fokin, V. V.; Finn, M. G.;
Sharpless, K. B. Aust. J. Chem. 2007, 60, 381. (c) Lutz,
J.-F. Angew. Chem. Int. Ed. 2007, 46, 1018.
(7) Dondoni, A. Chem. Asian. J. 2007, 2, 700.
(8) Feldman, A. K.; Colasson, B.; Fokin, V. V. Org. Lett. 2004,
47, 3897.
(9) Yadav, J. S.; Subba Reddy, B. V.; Madhusudham Reddy,
G.; Narasimha Chary, D. Tetrahedron Lett. 2007, 9, 8773.
(10) Chandrasekhar, S.; Basu, D.; Rambabu, C. Tetrahedron Lett.
2006, 47, 3059.
Synlett 2008, No. 14, 2089–2092 © Thieme Stuttgart · New York